Research necessary for clinical consideration of authorizing medical cannabis
| Factor | No. (%) of interviews | No. (%) of coded references |
|---|---|---|
| Data from any scientific method | 15 (83) | 61 (3.2) |
| Appropriate use | 10 (56) | 42 (2.2) |
| Adverse effects | 11 (61) | 41 (2.2) |
| Efficacy | 10 (56) | 23 (1.2) |
| Safety | 10 (56) | 23 (1.2) |
| Randomized controlled clinical trials | 13 (72) | 19 (1.0) |
| Dosing | 9 (50) | 19 (1.0) |